Borres, Julia P.
HRN: 20-43-81 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
06/17/2022
CEFUROXIME 750MG (VIAL)
06/17/2022
06/24/2022
IV
250 Mg
Q8hrs
PCAP- C, AGE Mod Dehydration
Waiting Final Action
Indication: Empiric Type of Infection: Pneumonia Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes